Plasma Levels of CGRP and Expression of Specific microRNAs in Blood Cells of Episodic and Chronic Migraine Subjects
NCT04473976 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 55
Last updated 2020-07-20
Summary
Migraine can manifest with an episodic or chronic pattern in a continuum of disease severity. Multiple factors are associated to the transformation of the pattern form episodic to chronic. Of these, the most consistently reported is the overuse of medications (MO) for the acute treatment of attacks. Knowledge of the mechanisms through which MO facilitates the transformation of episodic migraine (EM) into chronic migraine (CM) is very limited. In order insights into these mechanisms, the present study was aimed at identifying possible peripheral biomarkers associated to the 2 forms of migraine and to the presence of MO.
The investigators evaluated CGRP plasma levels and the expression of miR-34a-5p and miR-382-5p in peripheral blood mononuclear cells of subjects with episodic migraine (EM, n=27) and CM-MO (n=28). CM-MO group was also tested 2 months after an in-hospital detoxification protocol.
Conditions
Sponsors & Collaborators
-
University of Pavia
collaborator OTHER -
IRCCS National Neurological Institute "C. Mondino" Foundation
lead OTHER
Principal Investigators
-
Cristina Tassorelli, Prof · IRCCS Mondino Foundation, Pavia
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-12-15
- Primary Completion
- 2019-04-15
- Completion
- 2019-06-15
Countries
- Italy
Study Locations
More Related Trials
-
Calcitonin Gene-related Peptide in Familial Hemiplegic Migraine (FHM) and Migraine With Aura (MA)
NCT00687947 ·Status: COMPLETED ·Phase: NA
-
Psychological and Biological Markers of Refractory Migraine
NCT05046119 ·Status: UNKNOWN
-
KETOMIGRAINE: Ketogenic Diet in Drug-resistant Chronic Migraineurs
NCT05313503 ·Status: UNKNOWN ·Phase: NA
-
Inflammatory Markers in Patients With Active Migraine Headaches
NCT00471861 ·Status: COMPLETED
-
Biochemical Profiling of Migraine Patients
NCT06549270 ·Status: RECRUITING
-
Correlation of Calcitonin Gene-Related Peptide (CGRP) Levels in Saliva With the Evolution of an Attack of Migraine
NCT00772473 ·Status: COMPLETED
-
The Role of CGRPand Nociceptin in Migraine
NCT00155129 ·Status: UNKNOWN
-
Molecular Phenotyping of Migraine Patients According to Sex and Age Through CGRP Quantification
NCT06674772 ·Status: RECRUITING
-
Study of the Glymphatic System in Migraine
NCT05907655 ·Status: RECRUITING
-
Searching for Novel Therapeutic Approaches in Migraine Patients Resistant to Treatments
NCT06562400 ·Status: RECRUITING
-
miR-155 Expression in Episodic and Chronic Migraine
NCT05891808 ·Status: UNKNOWN
-
Stimulation-evoked Calcitonin Gene-Related Peptide (CGRP) as Biomarker of Migraine
NCT05768828 ·Status: UNKNOWN
-
Efficacy of OnabotulinumtoxinA in Migraine
NCT04578782 ·Status: COMPLETED ·Phase: PHASE2
-
Neurophysiological, Biomolecular and Psychological Aspects of Erenumab Treatment in Chronic Migraine
NCT04361721 ·Status: UNKNOWN
-
Nutritional Intervention in Migraine
NCT02703129 ·Status: COMPLETED ·Phase: NA
-
Neurophysiology of Prophylactic Treatment in Migraine
NCT04019496 ·Status: COMPLETED
-
Transcriptomic and Biochemical Changes During a Migraine Attack
NCT02468622 ·Status: COMPLETED
-
CGRP-induced Migraine Attacks in Patients Who Have Tried Anti-CGRP Monoclonal Antibody Treatment
NCT03481400 ·Status: UNKNOWN ·Phase: NA
-
The Hemodynamic Effects of CGRP After Glibenclamide Administration in Healthy Volunteers
NCT04231617 ·Status: COMPLETED ·Phase: NA
-
Pain Control in Episodic and Chronic Migraine
NCT06599905 ·Status: COMPLETED ·Phase: NA
-
(Italian Migraine Registry, I-GRAINE-NEW)
NCT07163416 ·Status: RECRUITING
-
Migraine With Aura Inducing Characteristics and Effects on the Cerebral Arteries and Blood Flow by Hypoxia
NCT01896167 ·Status: COMPLETED ·Phase: NA
-
"Longitudinal Analysis of Amylin Levels in Migraine Patients Undergoing an Anti- CGRP/CGRPr Treatment"
NCT06692088 ·Status: NOT_YET_RECRUITING
-
Feasibility and Effectiveness of Home-behavioral Program for Adolescents With Migraine
NCT04604977 ·Status: COMPLETED ·Phase: NA
-
MicroRNA Profile and Erenumab Treatment
NCT04659226 ·Status: COMPLETED ·Phase: NA